OncoTherapy Science, Inc. engages in the research and development of antibody drugs. Its services include the research on cancer-related cells and genes, and develops cancer therapy products which include low molecular drugs, antibody drugs, cancer peptide vaccine, diagnostic medicine and nucleic acid drugs. The company was founded on April 6, 2001 and is headquartered in Kawasaki, Japan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company